ABG Analytics logo
Get updates

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 12/31/2020
Closing price: 58.26
Support price level: N/A
Resistance price level: $59.13
Relative strength index (14-day RSI) 34.5
Beta 0.39
  • GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • GILD is one of this month's worst performers with a return of -4.7%, underperforming 90 percent of stocks in the S&P-100.

  • The price of this low-beta stock is expected to increase by 0.39% for every 1% increase in the S&P-500.

  • Volatility is forecast to rise over the next month.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$56.65 $84.00 7.1%
200 day 50 day 20 day 10 day
$68.97 $59.62 $59.07 $57.68
(Annualized standard deviation)
(5 year)
Last month Current estimate Next month forecast
27.6% 21.8% 21.3% 26.8%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 5.8% in the next week.

  • 15.2% in the next month.

  • 61.2% in the next year.